The haematocrit – an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease

Gatzoulis MA, Webb GD, Daubeney PEF. Eisenmenger's Syndrome. In: Diagnosis and management of adult congenital heart disease. Churchill Livingstone. Edinburgh: Elsevier Limited,2006: 363–377. Tempe, 2002, Coagulation abnormalities in patients with cyanotic congenital heart disease, J Cardiothorac Vasc Anesth, 16, 752, 10.1053/jcan.2002.128436 Mamas, 2008, Embolisation of systemic-to-pulmonary collaterals in patients with the Eisenmenger reaction presenting with haemoptysis, Cardiol Young, 18, 528, 10.1017/S1047951108002680 Territo, 1991, Cyanotic congenital heart disease: Hematologic management, J Am Coll Cardiol, 18, 320, 10.1016/0735-1097(91)90572-Q Osthaus, 2008, Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases, Blood Coagul Fibrinolysis, 19, 220, 10.1097/MBC.0b013e3282f54532 Lill, 2006, Pathogenesis of thrombocytopenia in cyanotic congenital heart disease, Am J Cardiol, 98, 254, 10.1016/j.amjcard.2006.01.083 Peters, 1982, Platelet kinetics in congenital heart disease, Cardiovasc Res, 16, 391, 10.1093/cvr/16.7.391 Horigome, 2002, Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia, J Am Coll Cardiol, 39, 1072, 10.1016/S0735-1097(02)01718-7 Horigome, 2003, Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis, Thromb Res, 112, 223, 10.1016/j.thromres.2003.12.011 Kajimoto, 2007, Increased thrombogenesity in patients with cyanotic congenital heart disease, Circ J, 71, 948, 10.1253/circj.71.948 Caramuru, 2004, Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension, Clin Appl Thromb Hemost, 10, 217, 10.1177/107602960401000303 Shibata, 2003, Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis, Blood, 101, 4416, 10.1182/blood-2002-09-2814 Cui, 2009, Perioperative Monitoring of Thromboelastograph on Hemostasis and Therapy for Cyanotic Infants Undergoing Complex Cardiac Surgery, Artif Organs, 33, 909, 10.1111/j.1525-1594.2009.00914.x Lopes, 1989, Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension, Chest, 95, 1207, 10.1378/chest.95.6.1207 Sahoo, 2007, Effects of Hemodilution on Outcome After Modified Blalock-Taussig Shunt Operation in Children With Cyanotic Congenital Heart Disease, J Cardiothorac Vasc Anesth, 21, 179, 10.1053/j.jvca.2006.01.029 Terai, 1987, Thrombocytopenia in patients with aortopulmonary transposition and an intact ventricular septum, Br Heart J, 57, 371, 10.1136/hrt.57.4.371 Gersh, 2009, Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes, Thromb Haemost, 102, 1169, 10.1160/TH09-03-0199 Perloff, 1993, Risk of stroke in adults with cyanotic congenital heart disease, Circulation, 87, 1954, 10.1161/01.CIR.87.6.1954 Tay, 2011, Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome, Int J Cardiol, 151, 307, 10.1016/j.ijcard.2010.05.066 Maurer, 1975, Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction, Am J Cardiol, 35, 831, 10.1016/0002-9149(75)90119-8 Broberg, 2004, Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma, Heart, 90, e63, 10.1136/hrt.2004.039198 Jensen, 2007, Images in cardiovascular medicine. Pulmonary artery thrombosis and hemoptysis in Eisenmenger syndrome, Circulation, 115, e632, 10.1161/CIRCULATIONAHA.107.695312 Wood, 1958, The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I, Br Med J, 2, 701, 10.1136/bmj.2.5098.701